An update on oral human papillomavirus infection

Indian Journal of Sexually Transmitted Diseases and AIDS
Ankit H BhartiY S Marfatia

Abstract

Human papillomavirus (HPV) constitutes the majority of newly acquired sexually transmitted infections (STIs) in United States as per the centers for disease control factsheet 2013. Genital HPV is the most common STI with incidence of about 5.5 million world-wide, nearly 75% of sexually active men and women have been exposed to HPV at some point in their lives. Oral Sexual behavior is an important contributor to infection of HPV in the oral mucosa especially in cases known to practice high risk behavior and initiating the same at an early age. HPV infection of the oral mucosa currents is believed to affect 1-50% of the general population, depending on the method used for diagnosis. The immune system clears most HPV naturally within 2 years (about 90%), but the ones that persist can cause serious diseases. HPV is an essential carcinogen being implicated increasingly in association with cancers occurring at numerous sites in the body. Though there does not occur any specific treatment for the HPV infection, the diseases it causes are treatable such as genital warts, cervical and other cancers.

References

Aug 1, 1991·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·F ChangK Syrjänen
Aug 1, 1985·Oral Surgery, Oral Medicine, and Oral Pathology·C ScullyN Maitland
Mar 1, 1987·The Pediatric Infectious Disease Journal·R S Bennett, K R Powell
Sep 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·P MountsH Kashima
May 1, 1981·American Journal of Otolaryngology·A M CohnE Adam
Apr 12, 2001·The New England Journal of Medicine·J MorkJ Dillner
Oct 23, 2001·International Journal of Cancer. Journal International Du Cancer·D M ParkinP Pisani
Feb 10, 2004·The Journal of Infectious Diseases·Aimee R KreimerMaura L Gillison
May 12, 2004·Lancet·M L Gillison, D R Lowy
Jun 24, 2004·Archives of Otolaryngology--head & Neck Surgery·Michael J SilverbergKeerti V Shah
Nov 20, 2004·The Journal of Infectious Diseases·Nubia MuñozUNKNOWN Instituto Nacional de Cancerologia HPV Study Group
May 15, 2007·The New England Journal of Medicine·Gypsyamber D'SouzaMaura L Gillison
Jun 19, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N TermineG Campisi
Jul 17, 2008·Current HIV/AIDS Reports·Jennifer E Cameron, Michael E Hagensee
Jul 29, 2008·The Journal of Infectious Diseases·Anna R GiulianoRobin B Harris
Mar 27, 2009·The Journal of Infectious Diseases·Gypsyamber D'SouzaMaura L Gillison
Apr 22, 2009·Archives of Otolaryngology--head & Neck Surgery·Andrew G SikoraErich M Sturgis
Sep 25, 2009·Actas dermo-sifiliográficas·A Martorell-CalatayudC Guillén-Barona
Nov 26, 2009·Infectious Agents and Cancer·Liviu FellerJohan Lemmer
Apr 15, 2010·Journal of Health Communication·Alice ForsterJo Waller
Jul 20, 2011·Journal of Cancer Research and Therapeutics·K L Kumaraswamy, M Vidhya
Apr 9, 2013·Expert Review of Vaccines·Jong Sup Park, Sooyoung Hur

❮ Previous
Next ❯

Citations

Oct 7, 2014·Otolaryngologia polska. The Polish otolaryngology·Kamal MorshedMałgorzata Polz-Dacewicz
Dec 13, 2018·Indian Journal of Surgical Oncology·Deepa NairAnil D'Cruz
Jun 7, 2017·International Journal of Applied & Basic Medical Research·Atmakuri Shanmukha RamyaAyyagari Kameswara Rao
Sep 27, 2020·British Dental Journal·Chivani TailorStephen R Watt-Smith

❮ Previous
Next ❯

Methods Mentioned

BETA
surgical resection

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.